Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 4.01 -0.04 (0.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.05 | 52 Week High | $18.00 | |||
| Open | $4.04 | 52 Week Low | $6.91 | |||
| Day High | $4.07 | P/E | N/A | |||
| Day Low | $3.88 | EPS | $-0.67 | |||
| Volume | 531,509 | |||||
